Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...
Singapore: Institutional and retail investors of Bioxyne re-elected chairman Mr Ian Mutton and managing director Mr Dav...
Singapore: The US Agency for International Development (USAID) and the Australian Agency for International Development (...
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system that noninvasively measure...
Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access...
Singapore: Australian drug development company CBio will merge with US-based Inverseon in a deal to establish a clinical...
Singapore: Immunocore entered into a research collaboration and licensing agreement with Genentech, a member of the Roch...
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...
Singapore: Spinifex Pharmaceuticals announced that Dr Ronald Marcus would be the new Chief Medical Officer. He would be ...
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...
Singapore: Research from University of Adelaide have shown that immune cells known as macrophages are critical to fertil...
Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumati...
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...
Singapore: CardioCel, a cardiovascular tissue patch to repair heart deformities including repairing and reconstructing h...
Singapore: Australia-based medical device developer Aimedics, in consultation with Therapeutic Goods Administration (TGA...
Singapore: Benitec Biopharma and uniQure, a leader in the field of human gene therapy, announced a non-exclusive cross...
